BOT vs DXB

ASX Healthcare sector comparison — updated 14 Jul 2026 — Healthcare sector

BOT

BOTANIX FPO [BOT]

39LOW

DXB

DIMERIX FPO [DXB]

40LOW

Score Breakdown

BOT DXB
Technical
47
45
Catalyst
51
48
Sentiment
50
50
Fundamental
76
82
Momentum
29
36
Risk Gate
45
50

Key Metrics

BOT Metric DXB
$70.7MMarket Cap$141.1M
14.5MAvg Volume (20d)3.2M
+0.2%Short InterestN/A
$0.18052-Week High$0.665
$0.01852-Week Low$0.158
+0.0%Daily Change+2.1%
$0.025Reference Price$0.240
-121.1%ROE-594.5%
N/AProfit Margin-219.9%

Active Signals

BOT Signals

●Stochastic is stretched into overbought — could need a breather
●Beating the Small Ords index — relative strength of 1.17, so it's outpacing the pack
●Below the 200-day average — the long-term trend is still working against it
●Critical cash runway (1.6 quarters)
●Low P/S ratio (3.2x)
●Strong revenue growth (+4271%)
●EPS estimates revised upward (+10pts)
●Near 52-week low (5% of range)

DXB Signals

●Watch out — volume is flowing out even as price holds up. Distribution pattern
●Beating the Small Ords index — relative strength of 1.36, so it's outpacing the pack
●Below the 200-day average — the long-term trend is still working against it
●Cash positive / operating cashflow positive
●4C filed 2026-04-29
●Strong revenue growth (+636%)
●EPS estimates revised upward (+10pts)
●Near 52-week low (15% of range)

Ask Scout AI to compare BOT and DXB in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener

Related Comparisons

BOT vs ENL →BOT vs EZZ →BOT vs FRE →BOT vs HIQ →BOT vs ICR →
BOT Full Analysis → DXB Full Analysis → Healthcare Sector → All Comparisons →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).